Arteris Inc. officer Paul Alpern filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 18,500 shares of common stock through a stock option exercise under a Rule 10b5-1 plan.
Key Highlights
- Proposed sale: 18,500 shares of Arteris Inc. common stock with an aggregate market value of $355,200.00
- Acquisition method: Securities to be sold were acquired via exercise of stock options from the issuer on November 10, 2026
- Shares outstanding: 49,735,064 shares of common stock outstanding as of the filing date
- 10b5-1 plan date: The plan was adopted on February 23, 2026
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004
- Prior sales in past 3 months: Alpern sold a combined 20,151 shares across four transactions between September 1, 2026, and October 5, 2026, generating gross proceeds totaling $473,394.59
Alpern's Proposed Option Exercise and Sale at Arteris Inc.
Paul Alpern, an officer at Arteris Inc. (NASDAQ:AIP), submitted a Form 144 notice dated November 10, 2026, announcing a proposed sale of 18,500 shares of the company's common stock on NASDAQ. According to the filing, the shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services. The aggregate market value of the proposed sale is listed as $355,200.00. The filing states that the approximate date of sale is November 10, 2026.
The filing discloses that the securities to be sold were acquired through the exercise of stock options from the issuer, with both the date of acquisition and date of payment listed as November 10, 2026, and payment made in cash. The remarks section of the filing states: "The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale." Alpern relies on a Rule 10b5-1 trading plan adopted on February 23, 2026.
The filing also details prior sales of Arteris common stock by Alpern during the preceding three months. Four transactions are listed: 4,000 shares sold on September 1, 2026, with gross proceeds of $83,063.20; 6,500 shares on October 1, 2026, generating $154,933.25; 3,648 shares on October 2, 2026, generating $89,898.03; and 6,003 shares on October 5, 2026, generating $145,500.11. Three of these four transactions are identified as 10b5-1 sales. Arteris Inc. is headquartered at 900 E. Hamilton Ave., Suite 300, Campbell, California 95008.
What Was Disclosed
Arteris officer Paul Alpern filed a Form 144 proposing to sell 18,500 shares of common stock worth $355,200.00, acquired via stock option exercise, through a 10b5-1 plan adopted February 23, 2026, with the proposed sale dated November 10, 2026.



Please wait processing your request...